You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 11, 2025

List of Excipients in API latanoprostene bunod ophthalmic solution, 0.024%

✉ Email this page to a colleague

« Back to Dashboard

Excipients in ANDA-approved (generic) drugs containing latanoprostene bunod ophthalmic solution, 0.024%

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC	Excipient
Gland Pharma Limited	latanoprostene bunod ophthalmic solution, 0.024%	68083-563	ANHYDROUS CITRIC ACID
Gland Pharma Limited	latanoprostene bunod ophthalmic solution, 0.024%	68083-563	BENZALKONIUM CHLORIDE
Gland Pharma Limited	latanoprostene bunod ophthalmic solution, 0.024%	68083-563	EDETATE SODIUM
Gland Pharma Limited	latanoprostene bunod ophthalmic solution, 0.024%	68083-563	GLYCERIN
Gland Pharma Limited	latanoprostene bunod ophthalmic solution, 0.024%	68083-563	POLYSORBATE 80
Gland Pharma Limited	latanoprostene bunod ophthalmic solution, 0.024%	68083-563	TRISODIUM CITRATE DIHYDRATE
Gland Pharma Limited	latanoprostene bunod ophthalmic solution, 0.024%	68083-563	WATER
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for latanoprostene bunod ophthalmic solution, 0.024%

Excipient focus: ANHYDROUS CITRIC ACID

latanoprostene bunod ophthalmic solution, 0.024% drug variants containing ANHYDROUS CITRIC ACID

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Gland Pharma Limited	latanoprostene bunod ophthalmic solution, 0.024%	68083-563
>Company	>Ingredient	>NDC

latanoprostene bunod ophthalmic solution, 0.024% drug variants not containing ANHYDROUS CITRIC ACID

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: BENZALKONIUM CHLORIDE

latanoprostene bunod ophthalmic solution, 0.024% drug variants containing BENZALKONIUM CHLORIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Gland Pharma Limited	latanoprostene bunod ophthalmic solution, 0.024%	68083-563
>Company	>Ingredient	>NDC

latanoprostene bunod ophthalmic solution, 0.024% drug variants not containing BENZALKONIUM CHLORIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: EDETATE SODIUM

latanoprostene bunod ophthalmic solution, 0.024% drug variants containing EDETATE SODIUM

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Gland Pharma Limited	latanoprostene bunod ophthalmic solution, 0.024%	68083-563
>Company	>Ingredient	>NDC

latanoprostene bunod ophthalmic solution, 0.024% drug variants not containing EDETATE SODIUM

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: GLYCERIN

latanoprostene bunod ophthalmic solution, 0.024% drug variants containing GLYCERIN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Gland Pharma Limited	latanoprostene bunod ophthalmic solution, 0.024%	68083-563
>Company	>Ingredient	>NDC

latanoprostene bunod ophthalmic solution, 0.024% drug variants not containing GLYCERIN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYSORBATE 80

latanoprostene bunod ophthalmic solution, 0.024% drug variants containing POLYSORBATE 80

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Gland Pharma Limited	latanoprostene bunod ophthalmic solution, 0.024%	68083-563
>Company	>Ingredient	>NDC

latanoprostene bunod ophthalmic solution, 0.024% drug variants not containing POLYSORBATE 80

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TRISODIUM CITRATE DIHYDRATE

latanoprostene bunod ophthalmic solution, 0.024% drug variants containing TRISODIUM CITRATE DIHYDRATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Gland Pharma Limited	latanoprostene bunod ophthalmic solution, 0.024%	68083-563
>Company	>Ingredient	>NDC

latanoprostene bunod ophthalmic solution, 0.024% drug variants not containing TRISODIUM CITRATE DIHYDRATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: WATER

latanoprostene bunod ophthalmic solution, 0.024% drug variants containing WATER

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Gland Pharma Limited	latanoprostene bunod ophthalmic solution, 0.024%	68083-563
>Company	>Ingredient	>NDC

latanoprostene bunod ophthalmic solution, 0.024% drug variants not containing WATER

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.